Diffusion Pharmaceuticals Inc (DFFN) Stock
DFFN is no longer traded. Diffusion Pharmaceuticals was delisted from the Nasdaq in October 2023.
Prices on this page are historical; the last trade was October 18, 2023 at $9.25.
Diffusion Pharmaceuticals stock price history
DFFN final trading statistics
- Final close
- $9.25
- Final trading day
- Oct 18, 2023
- Market cap at delisting
- $8.98M
- Shares outstanding
- 2.04M
- Final 52-week range
- $2.76 – $14.37
- Avg. volume (final 3 mo.)
- 61,831
- All-time high (split-adj.)
- $1000000.00 · Jul 1996
- All-time low (split-adj.)
- $4.20 · Jul 2023
- Return since IPO
- -100.0%
- Beta
- 1.76
- Book value / share
- $6.97
- Price / book
- 1.33
Diffusion Pharmaceuticals annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$15.2M | -$7.65 |
| FY2021 | $0.00 | -$24.1M | -$8.50 |
| FY2020 | $0.00 | -$14.2M | -$13.00 |
| FY2019 | $0.00 | -$11.8M | -$107.50 |
| FY2018 | $0.00 | -$18.4M | -$305.50 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Diffusion Pharmaceuticals Inc
Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.
Diffusion Pharmaceuticals stock FAQ
What happened to Diffusion Pharmaceuticals stock?
Diffusion Pharmaceuticals stock was delisted from the Nasdaq. Its final close was $9.25 on October 18, 2023.
Is DFFN stock still trading?
No. DFFN was delisted from the Nasdaq in October 2023 and no longer trades on a U.S. exchange.
What was the last price of DFFN stock?
DFFN closed at $9.25 on its final trading day, October 18, 2023, for a market value of about $8.98M.
What were Diffusion Pharmaceuticals's revenue and earnings in its last full fiscal year?
Diffusion Pharmaceuticals reported revenue of $0.00 and net income of -$15.2M in fiscal 2022, its last full year as a public company.
When did Diffusion Pharmaceuticals go public?
Diffusion Pharmaceuticals Inc stock began trading on January 4, 2016.